Overview
CIC101-01-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.
Description
The long-term safety of TRTP-101 was evaluated by participants in the CIC101-01 clinical trial and followed up for 5 years for serious adverse events.
Eligibility
Inclusion Criteria:
- Received TRTP-101 in clinical trial CIC101-01
- Provided written informed consent to participate in this study
Exclusion Criteria:
- Judged to be unsuitable to participate in this long-term follow-up